<DOC>
	<DOCNO>NCT01843530</DOCNO>
	<brief_summary>This trial randomize , double-blind , two arm , multicenter , Phase III study Berinert treatment ACE induce Angioedema . This study show Berinert shorten time complete resolution sign symptom acute ACE-induced angioedema upper airway tract compare placebo give top standard treatment . This study also compare time onset relief define least one point reduction severity scale ACE-induced angioedema Berinert versus placebo .</brief_summary>
	<brief_title>Randomized , Double-blind , Two Arms , Multicenter , Phase III Study Berinert Treatment ACE Induced Angioedema</brief_title>
	<detailed_description />
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Complement C1 Inactivator Proteins</mesh_term>
	<mesh_term>Cortisone acetate</mesh_term>
	<mesh_term>Cortisone</mesh_term>
	<criteria>Written inform consent participate study ability fulfil study requirement Male female patient age &gt; =18 year Patients ACE induce angioedema ( grade IIIII ) imminent airway obstruction admit Emergency department Patient treat ACEi Patient must acute angioedema attack cause ACEi Treatment administer within 10 hour onset angioedema Patients angioedema head and/or neck ( face , lip , cheek , tongue , soft palate/uvula , pharynx larynx ) Male participant female participant capable bearing child use method contraception medically approve health authority respective country Signed patient information consent form Diagnosis angioedema genesis : e.g . hereditary angioedema , C1inhibitor deficiency , allergic edema , anaphylaxis , insect bite , trauma , abscess , local inflammation , local tumour , postoperative postradiogenic edema , salivary gland disorder Participation clinical study past 30 day Patients simultaneous itchiness skin ( acute urticaria ) Patients history angioedema take ACEi History hypersensitivity study drug medicine similar chemical structure . Pregnancy and/or breastfeed Mental retardation patient restriction general judgment awareness History drug abuse ( include alcohol alcoholic liver disorder ) Potentially unreliable patient Patients suitable study opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>